For management purposes, the Group is organised into business units based on its geographical locations and it was determined that
there are two reportable segments:
Australia – corporate and administrative function
Europe – production and supply of medicinal cannabis products
The Europe operations relate to MGC Slovenia, MGC Derma and Panax which, based on their level of activities for the year ended
30 June 2018, have been aggregated as one reportable operating segment as each company exhibit similar economic characteristics
in respect of their inputs, processes, outputs and their regulatory environments, being that of the production and sale of medicinal
cannabis for pharmaceutical and cosmetic purposes.
Notes to the Financial Statements
| Annual Report 2018